Multiplexed Plasmonic Nano-Labeling for Bioimaging of Cytological Stained Samples

Cancers (Basel). 2021 Jul 13;13(14):3509. doi: 10.3390/cancers13143509.

Abstract

Reliable cytopathological diagnosis requires new methods and approaches for the rapid and accurate determination of all cell types. This is especially important when the number of cells is limited, such as in the cytological samples of fine-needle biopsy. Immunoplasmonic-multiplexed- labeling may be one of the emerging solutions to such problems. However, to be accepted and used by the practicing pathologists, new methods must be compatible and complementary with existing cytopathology approaches where counterstaining is central to the correct interpretation of immunolabeling. In addition, the optical detection and imaging setup for immunoplasmonic-multiplexed-labeling must be implemented on the same cytopathological microscope, not interfere with standard H&E imaging, and operate as a second easy-to-use imaging method. In this article, we present multiplex imaging of four types of nanoplasmonic markers on two types of H&E-stained cytological specimens (formalin-fixed paraffin embedded and non-embedded adherent cancer cells) using a specially designed adapter for SI dark-field microscopy. The obtained results confirm the effectiveness of the proposed optical method for quantitative and multiplex identification of various plasmonic NPs, and the possibility of using immunoplasmonic-multiplexed-labeling for cytopathological diagnostics.

Keywords: bioimaging; cytopathological cancer diagnosis; gold nanoparticles; gold-silver alloy nanoparticles; immunoplasmonic-multiplexed-labeling; paraffin-embedded cytological tissues; plasmonic biomarkers; side-illumination microscopy.